Skip to main content
. 2018 Sep 21;8:14161. doi: 10.1038/s41598-018-32256-x

Figure 4.

Figure 4

Autophagy inhibition synergizes with Vps34 inhibition or macropinocytosis inhibition to selectively inhibit proliferation of Tsc2-deficient cells. (A) Immunoblots confirmed Tsc2 downregulation in Atg5+/+ and Atg5−/− MEFs. The blot was cropped to highlight the relevant bands. The full-length blot is presented in Supplementary Figure 5A. (B) Proliferation of Atg5−/− shTsc2 MEFs grown in 1% FBS DMEM was selectively inhibited by Vps34 inhibitor SAR405 (2 uM, 48 hours). (C) Vps34 downregulation sensitized Tsc2−/− MEFs to CQ treatment (5 uM, 72 hours). (D) Proliferation of Atg5−/− shTsc2 MEFs grown in 1% FBS DMEM was selectively inhibited by the macropinocytosis inhibitor EIPA (6 uM, 48 hours). Data represented as mean +/− standard deviation of six biological replicates. Statistical significance was assessed using two-way and one-way ANOVAs with Bonferroni correction with *p < 0.05, ***p < 0.001, ****p < 0.0001. ƚp < 0.05, ƚƚƚƚp < 0.0001 when comparing treated to vehicle treatment in same cell type.